4G Clinical Revenue and Competitors

Claim your profile

Boston, MA USA

Location

$252.1M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • 4G Clinical's estimated annual revenue is currently $114M per year.(i)
  • 4G Clinical received $5.0M in venture funding in October 2016.
  • 4G Clinical's estimated revenue per employee is $281,400
  • 4G Clinical's total funding is $252.1M.

Employee Data

  • 4G Clinical has 405 Employees.(i)
  • 4G Clinical grew their employee count by 82% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$584.7M28209%$20MN/A

4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. Our expert staff possesses a combination of humility, confidence, curiosity and commitment to getting things done. Most importantly, everyone at 4G Clinical is passionate about our mission of bringing crucial medicines to those who need them, faster. For access to industry best practices and RTSM resources please visit www.4gclinical.com/resources.

keywords:N/A

$252.1M

Total Funding

405

Number of Employees

$114M

Revenue (est)

82%

Employee Growth %

N/A

Valuation

N/A

Accelerator

4G Clinical News

2022-04-20 - Bethesda Health Care taps Microsoft for PAS

... a range of other Microsoft technologies, in uploading encrypted pathology test results and clinical observations via 4G mobile network.

2021-06-30 - Daily funding roundup - June 30th, 2021

HealthVerity raised $100M; Babson Diagnostics landed $31M; Pathpoint secured $30M 4G Clinical: 4G Clinical is a Wellesley, Ma.-based company that creates software to run the back-end of clinical trials. 4G Clinical has raised more than $200 million in a new growth equity round led by Goldman Sa ...

2021-06-29 - 4G Clinical Raises $230M in Funding

4G Clinical, a Wellesley, MA-based randomization and trial supply management (RTSM) company, raised $230M in funding. The round was led by Goldman Sachs Asset Management. The company intends to use the funds for global expansion. Founded in 2015 by David Kelleher and Ed Tourtellotte, 4G Clini ...

2021-06-29 - 4G Clinical Announces $230MM Growth Equity Investment Backed by Goldman Sachs Asset Management Deutschland - Deutsch France - Français España - español USA - English

WELLESLEY, Mass. and NEW YORK, June 29, 2021 /PRNewswire/ -- 4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company, announced it has entered into an agreement to receive a growth equity investment of over $230MM from Goldman Sachs Asset Management ("Goldman Sachs ...

2019-09-08 - Pharma Clinical Trial Digitization Market Research Report ...

The report on Pharma Clinical Trial Digitization Market added by ... Antidote Technologies, Inc., ConsilX, 4G Clinical, CliniOps Inc, CRF, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$231.4M787-6%N/A
#2
$251.2M997N/AN/A
#3
$75M10191%N/A
#4
$570.8M1510-17%N/A
#5
$541.9M15808%N/A

4G Clinical Funding

DateAmountRoundLead InvestorsReference
2016-01-20$2.5MASchooner CapitalArticle
2016-10-20$5.0MA1Schooner CapitalArticle